A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case report

Neuroendocrine tumors (NET) are rare and demonstrate variable clinical behavior depending on the degree of tumor differentiation. Patients with poorly differentiated tumors (NET G3) have a poor prognosis. Systemic treatment with cytotoxic chemotherapy is considered to be the treatment of choice. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Özdirik, Burcin, Amthauer, Holger, Schatka, Imke, Goretzki, Peter E., Mogl, Martina T., Fehrenbach, Uli, Tacke, Frank, Jann, Henning, Roderburg, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725216/
https://www.ncbi.nlm.nih.gov/pubmed/33363730
http://dx.doi.org/10.3892/mco.2020.2182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725216/
https://www.ncbi.nlm.nih.gov/pubmed/33363730
http://dx.doi.org/10.3892/mco.2020.2182

Ejemplares similares